Menu
07 May, 2020

Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry

Correspondence in Nature Medicine

By Paul Hofman, Pascal Puchois, Patrick Brest, Hicham Lahlou and Daniel Simeon-Dubach